Allergy

TRIPLE-A

(_Assisting and _Accommodating _Allergy Patients)

The TRIPLE-A study evaluates patients’ experiences and/or perceptions of premedications and preventative medications prescribed while undergoing Allergy Immunotherapy (Subcutaneous (SCIT) or Transdermal (TdIT)).

Become a Study Investigator

To learn more about our TRIPLE-A study, please call our dedicated Healthcare Provider Help Desk at

(800) 616-9403.

Outcomes

The TRIPLE-A study is underway. We look forward to sharing data as soon as it is available.

Conference Highlights

MORE CONFERENCES

Become a Study Investigator

To learn more about our TRIPLE-A study, please call our dedicated Healthcare Provider Help Desk at

(800) 616-9403.